Philip Morris International Inc. (PM) Kapitalizatsiyaning foydaga nisbati

Philip Morris International Inc. (PM) korporativ emblemasi va logotipi

Hukumatning qat'iy nazorati va yuqori to'lovlar raqobatchilar uchun yengib bo'lmas texnologik to'siqni yaratadi. Philip Morris International (PM) kompaniyasining kuchli siyosiy ta'siri yangi qonunchilik cheklovlarining oldini olishga samarali yordam beradi. Foyda nisbati (P/E) biznesning haqiqiy qiymatini baholash imkonini beradi, bunda 29.20 ushbu metrikaning darajasini ko'rsatadi. Ushbu grafik IQOS tizimiga o'tish strategiyasining muvaffaqiyati va muqobil mahsulotlar orqali AQSh bozoriga kengayishni tasdiqlaydi.

Philip Morris International Inc - PM Narxning foydaga nisbati (davr: 04.07.2022 - 15.11.2026)

pmi.com (PM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning har tomonlama tahlili:Philip Morris
Philip Morris International yetakchi tovari

Koeffitsient bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadi va yillik daromadning bir dollari uchun xarajatni aks ettiradi. Ushbu ko'rsatkich investitsiyalarning qoplanish muddatini o'lchab, aktivning haddan tashqari qimmat yoki arzon baholanganligini bildiradi. Philip Morris International (PM) uchun ushbu metrikaning samaradorligi xavfsiz logistika va qalbaki mahsulotlarga qarshi kurashga sarflanadigan xarajatlarga bog'liq. Philip Morris International (PM) ning P/E tarixini tahlil qilish orqali investor joriy narxning biznesning pul oqimini yaratish qobiliyati bilan asoslanganligini aniqlashi mumkin.

Muhim raqobatchilar

British American Tobacco p.l.c. - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati altria.com (MO)|BUD - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Diageo PLC DEO|Constellation Brands (STZ) - Kapitalizatsiyaning foydaga nisbati|BF-A - Narxning foydaga nisbati|TAP (Molson Coors Brewing Company) - Narx-foyda multiplikatori|SAM (Samuel Adams) - Narx-foyda koeffitsiyenti|RLX Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TPB|Narx-foyda multiplikatori UVV (Universal Corporation)|P/E multiplikatori TLRY|SNDL Inc - Narx-foyda multiplikatori|Narxning foydaga nisbati MGP Ingredients MGPI|Biznesning o‘zini qoplash muddati Epsium Enterprise Corp (EPSM)|OGI - Narxning foydaga nisbati|WM Technology, Inc. - Bozor narxining sof foydaga nisbati|Ispire (ISPR) - Narxning foydaga nisbati|Narx-foyda multiplikatori IXHL|Narxning foydaga nisbati wvv.com|P/E multiplikatori lqrhouse.com|Narxning foydaga nisbati 22nd Century (XXII)|KAVL (Kaival Brands Innovations Group) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Innovation Beverage Corp IBG|heritagedistilling.com (CASK) - Kapitalizatsiyaning foydaga nisbati|Papa Medical Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati EAST (Eastside Distilling, Inc.)|Leafly Holdings, Inc. (LFLY) - Narxning foydaga nisbati|LQR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Duckhorn|VINE: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti VWE (Vintage Wine Estates, Inc.)|Biznesning o‘zini qoplash muddati CEA Industries, Inc.